Last Posted: Jun 15, 2017
A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy.
Weiss Glen J et al. PloS one 2017 12(6) e0179170
Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia.
Cavic Milena et al. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 21(5) 1287-1295
Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.
Ess S M et al. European journal of cancer care 2017 May
Seeing the Forest through the Phylogenetic Tree.
Robles Ana I et al. The New England journal of medicine 2017 Jun 376(22) 2190-2191
Seeing the Forest through the Phylogenetic Tree
AI Robles et al, NEJM, May 31, 2017
Tracking the Evolution of NonSmall-Cell Lung Cancer
MJ Hanjani et al, NEJM et al, June 1, 2017
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.